Z-0594-2019 Class II Terminated
FDA device recall Z-0594-2019 was initiated by Helena Laboratories, Inc. on April 20, 2016 and is designated Class II. Reason for recall: Due to some cards in this lot experiencing variations in wave form, resulting in some cards with shorter or longer times than expected The recall status is terminated (terminated February 15, 2024). Affected quantity: 12 Kits.
Recall Details
- Product Type
- Devices
- Report Date
- December 19, 2018
- Initiation Date
- April 20, 2016
- Termination Date
- February 15, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 12 Kits
Product Description
Cascade Abrazo c-ACT-LR Test Card IVD FOR IN VITRO DIAGNOSTIC USE Store at 2 to 8 C HELENA LABORATORIES 003366 12/13(2) FOR EXPORT ONLY The Cascade Abrazo c-ACT-LR test cards are activated clotting time tests to be used with the Cascade Abrazo analyzer and are intended to monitor the effect of low to moderate heparin on coagulation in fresh whole blood.
Reason for Recall
Due to some cards in this lot experiencing variations in wave form, resulting in some cards with shorter or longer times than expected
Distribution Pattern
US Distribution to state of TX and internationally to: Australia, Netherlands, Italy, and England.
Code Information
Lot Codes: 1-15-5701 Model/Catalog Number: 5701